AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes
The International Journal of Biochemistry & Cell Biology · 2024
DOI: 10.1016/j.biocel.2024.106539 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Jiawen Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Research Center of Biostatistics and Computational Pharmacy, Chin…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, NF-E2-Related Factor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin (DOX), a widely used chemotherapy agent in cancer treatment, encounters limitations in clinical efficacy due to associated cardiotoxicity. This study aims to explore the role of AKT serine/threonine kinase 2 (AKT2) in mitigating DOX-induced oxidative stress within the heart through both intracellular and extracellular signaling pathways. Utilizing Akt2 knockout (KO) and Nrf2 KO murine models, alongside neonatal rat cardiomyocytes (NRCMs), we systematically investigate the impact of AKT2 deficiency on DOX-induced cardiac injury. Our findings reveal that DOX administration induces significant oxidative stress, a primary contributor to cardiac injury. Importantly, Akt2 deficiency exhibits a protective effect by alleviating DOX-induced oxidative stress. Mechanistically, Akt2 deficiency facilitates nuclear translocation of NRF2, thereby suppressing intracellular oxidative stress by promoting the expression of antioxidant genes. Furthermore, We also observed that AKT2 inhibition facilitates superoxide dismutase 2 (SOD2) expression both inside macrophages and SOD2 secretion to the extracellular matrix, which is involved in lowering oxidative stress in cardiomyocytes upon DOX stimulation. The present study underscores the important role of AKT2 in mitigating DOX-induced oxidative stress through both intracellular and extracellular signaling pathways. Additionally, our findings propose promising therapeutic strategies for addressing DOX-induced cardiomyopathy in clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing 210009, China; School of Life Sci…
- School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
- Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
- Clinical Pharmacology and Bioanalytics, Pfizer (China) Research and Development Co., Ltd, China.
- Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing 210009, China. Electronic address: 1020051138@cpu.edu.cn.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China. Electronic address: junmeiye@cpu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Xu, X., Shao, Y., Bian, X., Li, R., Zhang, Y., Xiao, Y., Lu, M., Jiang, Q., Zeng, Y., Yan, F., Ye, J., & Li, Z. (2024). AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106539
Vancouver
Chen J, Xu X, Shao Y, Bian X, Li R, Zhang Y, et al. AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106539
BibTeX
@article{Chen2024,
author = {Chen, Jiawen and Xu, Xiaozhi and Shao, Yuru and Bian, Xiaohong and Li, Ruiyan and Zhang, Yubin and Xiao, Yibei and Lu, Meiling and Jiang, Qizhou and Zeng, Yuan and Yan, Fangrong and Ye, Junmei and Li, Zhe},
title = {AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2024},
doi = {10.1016/j.biocel.2024.106539}
}
EUVIMED